Trials / Withdrawn
WithdrawnNCT01413854
Diclofenac add-on to Treatment as Usual for Suicidal Patients
"Antiinflammatoriska läkemedels Effekt för Att Minska Suicidalitet Hos Deprimerade Patienter Som Nyligen Har Gjort självmordsförsök"
- Status
- Withdrawn
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Region Skane · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether diclofenac is effective in the treatment of depressed patients with a recent suicide attempt.
Detailed description
The study will start with a feasibility study including treatment of 10 patients with diclofenac.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sugar pill | One tablet two times daily during four weeks |
| DRUG | Diclofenac | 50 mg, two times daily (oral adm.) during four weeks |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2011-08-01
- Completion
- 2011-08-01
- First posted
- 2011-08-10
- Last updated
- 2019-01-10
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01413854. Inclusion in this directory is not an endorsement.